Elevance Health Inc

Rule 10b5-1 Trading Plans

During the three months ended June 30, 2024, the following directors and officers (as defined in Rule-1(f) of the Exchange Act)adopted, modified orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement”, as each term is defined in Item 408 of Regulation S-K.

•Gail Boudreaux, President and Chief Executive Officer and member of our Board of Directors, adopted a stock trading plan on April 19, 2024, pursuant to which she may sell up to 34,000 shares of our common stock prior to October 31, 2024.

•Ramiro Peru, a member of our Board of Directors, adopted a stock trading plan on May 6, 2024, pursuant to which he may sell up to 753 shares of the Company’s common stock prior to May 6, 2025.

•Mark Kaye, Executive Vice President and Chief Financial Officer, adopted a stock trading plan on April 22, 2024, pursuant to which he may sell up to 6,758 shares of our common stock prior to February 28, 2025.

-53-

Each of these trading plans was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended, and the Company’s policies regarding transactions in our securities.